RenovoRx, Inc. (RNXT)
Nasdaq: RNXT · Pharmaceutical Preparations · Mountain View, CA · filing with the SEC since 2013
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Mar 30, 2026 | Apr 1, 2025 | Apr 1, 2024 | Mar 31, 2023 | Mar 30, 2022 | · |
| Revenue | 1,123 | 43 | · | · | · | · |
| For lenders | ||||||
| Net interest income | · | · | · | · | -834 | -587 |
| Cost of revenue | 327 | 0 | · | · | · | · |
| Gross profit | 796 | 43 | · | · | · | · |
| Research and development | 6,269 | 6,025 | 5,667 | 4,301 | 3,039 | 2,386 |
| Selling, general and administrative | 7,037 | 4,988 | 5,729 | · | · | · |
| General and administrative | · | · | 5,729 | 5,649 | 2,632 | 818 |
| Total operating expenses | 13,306 | 11,013 | 11,396 | 9,950 | 5,671 | 3,204 |
| Operating income | -12,510 | -10,970 | -11,396 | -9,950 | -5,671 | -3,204 |
| Interest income (expense), net | 427 | 384 | 108 | 57 | -834 | · |
| Other income (expense), net | · | · | · | 4 | 119 | -7 |
| Total non-operating income (expense) | 1,342 | 2,156 | 1,164 | 61 | -653 | -594 |
| Income before income taxes | -11,167 | -8,754 | · | · | · | · |
| Income tax expense | 2 | · | · | · | · | · |
| Net income | -11,168 | -8,814 | -10,232 | -9,889 | -6,324 | -3,798 |
| Earnings per share, basic | -0.32 | -0.40 | -0.99 | -1.09 | -1.21 | · |
| Earnings per share, diluted | -0.32 | -0.40 | -0.99 | -1.09 | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.21 | -1.72 |
| Weighted average shares, basic | 35,333,127 | 22,271,163 | 10,290,667 | 9,051,726 | 5,217,000 | · |
| Weighted average shares, diluted | 35,333,127 | 22,271,163 | 10,290,667 | 9,051,726 | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 5,217,000 | 2,214,000 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenuesNet interest income interest earned less interest paid
us-gaap:InterestIncomeExpenseNetCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfRevenueGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted